Are things at least starting to look better now?

[anonymous]

After the cardio protective news for Jardiance & Praxbind gaining approval, has there been a positive trajectory in Rxs in these respective markets?

Or

Is the same incompetence been demonstrated by leadership (i.e. Paul listens to the clueless Chris Marsh) and nothing has changed?!

 

[anonymous]

I am in respiratory, but it seems too soon to evaluate yet.